Australian public assessment for Fidaxomicin

The trial is aimed at over-50s, Patients presenting to GPs with a new, continuous cough or high temperature are being recruited. ... a systematic review from antiviral effects to COVID-19 complementary regimen. ... heart, kidney, endothelium, and skin. ACE2-expressing cells can act as home cells and are prone to SARS-CoV-2 infection as the ACE2 ... ................
................